This inventor holds 7 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Korea Research Institute of Bioscience and Biotechnology, Autotac Bio. Active years: 2006-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2006-2026
Title: Bo Yeon Kim: Innovator in Pharmaceutical Composition
Introduction
Bo Yeon Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with therapeutic applications. With a total of 7 patents to his name, Kim's work focuses on innovative solutions for treating various medical conditions.
Latest Patents
Among his latest patents, Kim has developed a benzofuran-based N-acylhydrazone derivative. This compound exhibits an excellent anticancer effect while maintaining low toxicity and high solubility. Consequently, the pharmaceutical composition comprising this derivative is useful for preventing or treating cell proliferative disorders, including various cancers. Another notable patent is an anti-inflammatory composition that includes an acylhydrazone derivative. This composition is designed to prevent, alleviate, or treat inflammatory diseases by effectively inhibiting inflammatory cytokines and signaling pathways, thereby alleviating symptoms of conditions such as dermatitis.
Career Highlights
Throughout his career, Bo Yeon Kim has worked with esteemed organizations, including the Korea Research Institute of Bioscience and Biotechnology and Autotac Bio. His research and innovations have significantly impacted the pharmaceutical industry, particularly in developing new therapeutic agents.
Collaborations
Kim has collaborated with notable colleagues, including Jong Seog Ahn and Jae-Hyuk Jang. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of pharmaceuticals.
Conclusion
Bo Yeon Kim's contributions to pharmaceutical innovation demonstrate his commitment to advancing medical science. His patents reflect a dedication to developing effective treatments for cancer and inflammatory diseases. Through his work, Kim continues to make a meaningful impact in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile